Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
Our current contract with GPPC is set to expire on 30th September 2025. In previous <br/>discussions, we have expressed an interest in extending this contract to align with the end <br/>date of GPPC’s agreement with the ICB. The aim is to synchronise timelines and better align <br/>strategic intentions moving forward.<br/>We are very satisfied with the service GPPC is providing. They are consistently exceeding <br/>expectations, delivering over 1,300 blood tests per week. The co-location of the blood <br/>service across primary and secondary care has proven to be both practical and beneficial.<br/>That said, we are also interested in exploring the feasibility of running an in-house pathology <br/>service. However, with the upcoming implementation of EPIC in October 2025, we feel now is <br/>not the appropriate time to initiate such a change. To allow us the necessary time to consider <br/>a longer-term strategy for delivering the blood service, we are proposing a 6-month PSR <br/>award. This would give us the space to evaluate future options, while recognising that GPPC <br/>also provide additional services at the CDC, including 24 hour tapes and Dermoscopy
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| GP Primary Choice (GPPC) | - | - | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 1 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 | - | 1 single bid — no competition | GP Primary Choice (GPPC) | active |
Weightings from the notice.